India, July 23 -- PharmEasy-owned Thyrocare's consolidated net profit for the quarter ended June 30, 2026 (Q1 FY27) zoomed 34% to Rs.51.3 Cr from Rs.38.3 Cr a year ago. Sequentially, profit rose 5.3% from Rs.48.7 Cr.

Revenue from operations jumped 24.4% to Rs.240 Cr during the quarter under review from Rs.193 Cr in Q1 FY26. On a sequential basis, it rose a little over 7% from Rs.224 Cr.

Total expenses grew 19.8% to Rs.176.6 Cr from Rs.147.5 Cr in Q1 FY26.

(The story will be updated soon)

The post PharmEasy-Owned Thyrocare's Q1 Profit Soars 34% To Rs.51 Cr appeared first on Inc42 Media.

Published by HT Digital Content Services with permission from Inc 42....